Investment Summary

Frazier Healthcare Partners Invests In Caravel Autism Health

On August 29, 2018, growth capital firm Frazier Healthcare Partners invested in healthcare services company Caravel Autism Health

Investment Highlights
  • This is Frazier Healthcare Partners’ 14th transaction in the Healthcare Services sector.
  • This is Frazier Healthcare Partners’ 33rd transaction in the United States.
  • This is Frazier Healthcare Partners’ 1st transaction in Wisconsin.

Investment Summary
Date 2018-08-29
Target Caravel Autism Health
Sector Healthcare Services
Investor(s) Frazier Healthcare Partners
Deal Type Growth Capital
Advisor(s) Triple Tree LLC (Financial)
Winston & Strawn
Husch Blackwell (Legal)

Target

Caravel Autism Health

Green Bay, Wisconsin, United States
Caravel Autism Health delivers in-home intensive, post-intensive, pre-intensive, and diagnostic evaluation services to children with Autism Spectrum Disorder. Caravel Autism Health emphasizes individualized goals based on proven, evidence-based treatment approaches mainly applied behavior analysis. Caravel Autism Health was founed in 2009 and is based in Green Bay, Wisconsin.

Search 201,771 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Frazier Healthcare Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1991
PE ASSETS 3.4B USD
Size Large
Type Sector Focused
DESCRIPTION

Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.

DEAL STATS #
Overall 34 of 48
Sector (Healthcare Services) 14 of 16
Type (Growth Capital) 7 of 7
State (Wisconsin) 1 of 1
Country (United States) 33 of 47
Year (2018) 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-16 Krystal Biotech

Pittsburgh, Pennsylvania, United States

Krystal Biotech is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases. Company have a proprietary gene therapy platform, which refer to as the Skin TARgeted Delivery platform, or STAR-D platform, which are initially using to develop treatments for rare or orphan dermatological indications. Krystal Biotech was founded in 2015 and is based in Pittsburgh, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-17 United Digestive

Atlanta, Georgia, United States

United Digestive provides a strong operational infrastructure for GI practices including regulatory assistance, managed care resources, and a full-service back-office that can be leveraged across a significantly larger geographic footprint. The company anticipates continued robust expansion through both near-term de-novo growth as well as complementary acquisitions and will bring operational best practices to additional GI practices while allowing providers to retain their clinical independence and a continued emphasis on high-quality patient care. United Digestive was formed in 2018 and is based in Atlanta, Georgia.

Buy -
Mergr

Product

Company

Legal